Cargando…
Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity
Renal cell carcinoma (RCC) is a common urologic disease. Currently, surgery is the primary treatment for renal cancer; immunotherapy is not as effective a treatment strategy as expected. Hence, understanding the mechanism in the tumor immune microenvironment (TME) and exploring novel immunotherapeut...
Autores principales: | Wang, He, Wang, Qibo, Wu, Yaoyao, Lou, Jianmin, Zhu, Shaoxing, Xu, Yipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017457/ https://www.ncbi.nlm.nih.gov/pubmed/36937841 http://dx.doi.org/10.3389/fphar.2023.1118217 |
Ejemplares similares
-
LAPTM4B promotes the progression of nasopharyngeal cancer
por: Su, Qun, et al.
Publicado: (2021) -
LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2019) -
Autophagy in renal fibrosis: Protection or promotion?
por: Dai, Rong, et al.
Publicado: (2022) -
Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022) -
YTHDF2 is a Potential Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Su, Ganglin, et al.
Publicado: (2021)